TCRX
USDTScan Therapeutics Inc. Common Stock
$1.120-0.050 (-4.274%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$1.170
最高
$1.250
最低
$1.080
交易量
0.81M
公司基本面
市值
63.6M
行業
生物科技
國家
United States
交易統計
平均交易量
0.51M
交易所
NGM
貨幣
USD
52週範圍
最低 $1.02當前 $1.120最高 $6.225
相關新聞
Analyst Upgrades
BTIG Downgrades TScan Therapeutics to Neutral
BTIG analyst Justin Zelin downgrades TScan Therapeutics from Buy to Neutral.
查看更多
Analyst Upgrades
Needham Maintains Buy on TScan Therapeutics, Lowers Price Target to $6
Needham analyst Gil Blum maintains TScan Therapeutics with a Buy and lowers the price target from $9 to $6.
查看更多
GlobeNewswire
TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027
Positive end of Phase I meeting and agreement reached with FDA on pivotal study design for TSC-101 Dosed first solid tumor patients with multiplex TCR-T therapy; paused further enrollment to prioritize heme development;
查看更多
